ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Open Label Extension to Bridging Study CTBM100C2303

Novartis Pharmaceuticals · 2009
ClinicalTrials.gov · Datasets · License: Public Domain · 2009
Open Source ↗
anti-bacterial-agentscystic-fibrosispseudomonas-aeruginosa
pseudomonas aeruginosa, cystic fibrosis, tobramycin inhalation powder, lung diseases, anti-bacterial agents, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832901
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.